Dual-Disease Protection in a Single Dose: Raksha HS+BQ provides simultaneous, scientifically validated protection against both Haemorrhagic Septicaemia and Black Quarter with a single 3 ml subcutaneous injection per animal, dramatically simplifying herd vaccination logistics and reducing the animal handling stress associated with multiple separate vaccination events. This combination approach ensures no gap in protection against either disease, even in resource-limited field conditions.

Proven Immunological Efficacy Against Two of Livestock's Deadliest Diseases: Both component antigens stimulate a robust, antigen-specific humoral immune response that confers meaningful protection before the onset of endemic transmission seasons. In vaccinated herds, the pre-formed antibody titres against P. multocida capsular antigens and C. chauvoei exotoxins are sufficient to neutralise pathogen and toxin load before systemic disease can establish, reducing herd morbidity and mortality to near zero under conditions of consistent annual vaccination.

Safe for Use in Pregnant Animals with Appropriate Precaution: Raksha HS+BQ is formulated to a standard that permits administration to pregnant cattle and buffalo, which is clinically important given that lactating and pregnant animals represent a significant proportion of productive livestock herds. Care should be taken in early pregnancy to avoid stress-related risks, and the attending veterinarian should supervise administration in animals in the first trimester.

Exceptional Safety Profile with No Risk from Overdose: Field and clinical data confirm that even accidental administration of a double dose does not produce adverse effects in cattle or buffalo, providing an additional margin of safety in field vaccination campaigns conducted across large herds where precise dosing may be challenging. Mild, transient swelling at the injection site may occasionally be observed, which resolves spontaneously.

Manufactured to WHO cGMP and ISO 9001 Standards by India's Premier Veterinary Biologicals Manufacturer: As an IIL product, Raksha HS+BQ is produced at one of the world's most advanced veterinary vaccine manufacturing facilities, operating under WHO cGMP certification, ISO 9001 compliance, and PIC/SRA GMP norms. This rigorous manufacturing oversight guarantees consistent antigen potency, sterility, and immunogenic efficacy across every batch released.

Critical Seasonal Protection in Climatically Vulnerable Livestock Populations: Outbreaks of both HS and BQ are strongly associated with environmental stressors including monsoon rains, high humidity, and temperature fluctuations. Timely pre-seasonal vaccination reinforces the herd's immune baseline precisely when natural susceptibility is highest, safeguarding livestock productivity, milk yields, and the economic security of farming communities dependent on their animals' health.

How to Use:

Raksha HS+BQ Vaccine must be administered by a registered veterinary practitioner or under direct veterinary supervision. Before drawing the vaccine, shake the vial thoroughly to ensure a uniform suspension of antigen particles. Allow the vaccine to reach room temperature before administration if stored under refrigeration, as cold injection may cause unnecessary discomfort. Clean and disinfect the injection site on the animal's neck or behind the shoulder with a suitable antiseptic before administration. Administer 3 ml of the vaccine by subcutaneous injection as a single dose. Primary vaccination is recommended from 6 months of age. Revaccinate annually, and where possible, schedule vaccination prior to the onset of seasonal risk periods such as the monsoon. In areas of high disease pressure or following periods of climatic stress, the attending veterinarian should advise on appropriate revaccination intervals. Do not administer to animals that are ill, severely debilitated, or undergoing concurrent febrile illness. Use a sterile needle and syringe for each animal to prevent transmission of disease between individuals. Do not mix with any other vaccine or biological product in the same syringe. Dispose of all used needles, syringes, and empty vials in accordance with applicable veterinary waste disposal regulations.

Storage Advice:

Store unopened Raksha HS+BQ Vaccine in a cool, dark, and dry place at a temperature between +2 degrees Celsius and +8 degrees Celsius at all times. Do not freeze, as freezing will irreversibly damage the aluminium hydroxide gel adjuvant and denature the inactivated antigens, rendering the vaccine ineffective. Protect from direct sunlight and heat exposure during storage and transport. Once opened, the multi-dose 90 ml polypropylene vial should be used within the same vaccination session and any remaining unused vaccine must be discarded safely in accordance with biohazard disposal guidelines. Do not use after the best-before date printed on the vial. Maintain a functional cold chain from the point of manufacture to the point of administration.

About the Brand:

Indian Immunologicals Limited (IIL) is a wholly owned subsidiary of the National Dairy Development Board (NDDB), established in 1982 in Hyderabad, India, with a founding mandate to make life-saving veterinary vaccines available to Indian farmers and livestock keepers at an accessible price. Over four decades of continuous scientific advancement, IIL has grown into one of Asia's foremost veterinary and human biologicals manufacturers, operating WHO cGMP-approved, ISO 9001-certified facilities and holding more than 300 international product registrations across 50-plus countries on every continent. The company's state-of-the-art Animal Health Formulations facility, approved under PIC and SRA GMP norms, underpins the rigorous quality and potency assurance that every Raksha-range vaccine carries. IIL is globally recognised as one of the top three producers of Foot and Mouth Disease vaccine in the world and the first and only manufacturer of a combined FMD, HS, and BQ vaccine, reflecting its unparalleled depth of expertise in multi-component veterinary immunology and its unwavering commitment to the One Health initiative. IIL's mission to innovate, produce, and market quality animal and human health products in service of farmers, practitioners, and animals around the world aligns with Animeal's commitment to bringing only the most credible, evidence-based veterinary health solutions to every livestock owner and animal caregiver we serve. Discover Indian Immunologicals today.

Disclaimer:

Please note that Raksha HS+BQ Vaccine is a prescription-only inactivated veterinary biological product formulated with formalin-killed antigens of Pasteurella multocida and Clostridium chauvoei adjuvanted with aluminium hydroxide gel, and is appropriate for use in cattle, buffalo, and calves from 6 months of age. It is a prophylactic vaccine intended to prevent Haemorrhagic Septicaemia and Black Quarter in healthy animals and is not a treatment for animals already infected with or showing clinical signs of either disease. Vaccination of clinically ill, immunocompromised, or severely debilitated animals may result in reduced or absent immune response. Administration during early pregnancy should be performed with caution and only under veterinary supervision due to the potential risk of stress-induced complications. Occasional transient swelling at the injection site and a mild rise in body temperature for one to two days following vaccination may be observed. In rare cases of suspected hypersensitivity reactions, consult your veterinarian immediately. This vaccine must be stored and transported under strict cold chain conditions; failure to maintain the required temperature range of +2 to +8 degrees Celsius will compromise potency. Animeal supports your livestock's health and productivity but does not replace the advice of a qualified veterinary professional.